Winthrop Advisory Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$381K Buy
1,052
+299
+40% +$102K 0.03% 146
2026
Q1
$265K Sell
753
-169
-18% -$60.2K 0.02% 160
2025
Q4
$302K Buy
922
+97
+12% +$30.8K 0.03% 140
2025
Q3
$233K Buy
825
+2
+0.2% +$580 0.02% 162
2025
Q2
$230K Buy
823
+19
+2% +$5.38K 0.02% 158
2025
Q1
$251K Sell
804
-35
-4% -$10.3K 0.03% 131
2024
Q4
$219K Buy
839
+154
+22% +$45.7K 0.03% 142
2024
Q3
$221K Buy
+685
New +$224K 0.03% 134

Other funds holding AMGN

Winthrop Advisory Group's AMGN Position: Q2 2026 in Review

Winthrop Advisory Group increased its Amgen (AMGN) stake by 40% in Q2 2026, buying an estimated $102K and bringing the position to 1,052 shares worth $381K. The position accounts for 0.03% of the portfolio, ranked #146.

Winthrop Advisory Group first reported a position in AMGN in Q3 2024 and has held it in 8 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Winthrop Advisory Group held 1,052 shares of Amgen worth $381K as of Q2 2026.
  • Winthrop Advisory Group bought 299 Amgen shares in Q2 2026, an estimated $102K.
  • Amgen made up 0.03% of Winthrop Advisory Group's portfolio in Q2 2026, its #146 holding.
  • Winthrop Advisory Group first reported a position in Amgen in Q3 2024 and has held it in 8 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Winthrop Advisory Group's 13F filing for Q2 2026, filed 17 Jul 2026.